During the past decade, Ankara University Medical Faculty Cebeci Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara University Medical Faculty Cebeci Hospital" #1 sponsor was "Celgene" with 8 trials, followed by "Ankara University" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Taiho Oncology, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University Medical Faculty Cebeci Hospital" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ankara University Medical Faculty Cebeci Hospital" are "Crohn Disease" (3 trials), "Multiple Myeloma" (3 trials), "Beta-thalassemia" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Ankara University Medical Faculty Cebeci Hospital" in a lesser frequency.

Most popular intervention types in "Ankara University Medical Faculty Cebeci Hospital" are "Drug" (10 trials), "Other" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Dexamethasone" (3 trials), "Ozanimod" (3 trials), "Pomalidomide" (3 trials) and "Luspatercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University Medical Faculty Cebeci Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Ankara University Medical Faculty Cebeci Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ankara University Medical Faculty Cebeci Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University Medical Faculty Cebeci Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".